New Delhi: As the country waits for a COVID vaccine for children before a possible third wave of the coronavirus pandemic hits India, a senior government official said on Friday that more data is needed before Zydus Cadila’s three-dose vaccine can be approved and cleared for children.
“Drugs Controller General of India (DCGI) is examining it. More data is needed. The scientific process has to be completed. We have to be lucky that it is effective and safe,” Dr VK Paul, member (health) of NITI Aayog, told ANI.
The Indian pharmaceutical company, based in Ahmedabad, applied to DCGI for emergency use authorisation on July 1. It sought approval of its DNA-based vaccine to be administered to all above the age of 12.
Once approved, ZyCoV-D will become India’s second indigenous anti-COVID vaccine after Bharat Biotech’s Covaxin.
Earlier in the day, the Centre told Delhi high court that trials for COVID vaccines on children below 18 are on the verge of completion.
AIIMS director Dr Randeep Guleria has said that Covaxin may be approved for children by September and Zydus’ vaccine will be “another option” once approved.
Bhubaneswar: Odisha unit of BJP has sought action by chief electoral officer (CEO) against BJD…
New Delhi: Around a thousand voters from across three villages in Gujarat boycotted voting for…
New Delhi: India has condemned the float used by pro-Khalistan elements at the 'Nagar Kirtan'…
Puri: Jagannath temple in Odisha's Puri town will remain closed to the devotees for six…
New Delhi: A group of men thrashed a medical aspirant in Kanpur after he was…
Bhubaneswar: After reeling under heatwave for nearly 3 weeks, Odisha heaved a sigh of relief…
New Delhi: Aam Aadmi Party (AAP) leader and MLA Amanatullah Khan's son was seen beating…
Phulbani: A hardcore Maoist cadre, who was wanted in several criminal cases, has surrendered before…